rs199703765

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP6BS1BS2

The NM_005198.5(CHKB):​c.14C>T​(p.Ala5Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000422 in 1,577,516 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00081 ( 0 hom., cov: 34)
Exomes 𝑓: 0.00038 ( 2 hom. )

Consequence

CHKB
NM_005198.5 missense

Scores

3
16

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.0100

Publications

2 publications found
Variant links:
Genes affected
CHKB (HGNC:1938): (choline kinase beta) Choline kinase (CK) and ethanolamine kinase (EK) catalyze the phosphorylation of choline/ethanolamine to phosphocholine/phosphoethanolamine. This is the first enzyme in the biosynthesis of phosphatidylcholine/phosphatidylethanolamine in all animal cells. The highly purified CKs from mammalian sources and their recombinant gene products have been shown to have EK activity also, indicating that both activities reside on the same protein. The choline kinase-like protein encoded by CHKL belongs to the choline/ethanolamine kinase family; however, its exact function is not known. Read-through transcripts are expressed from this locus that include exons from the downstream CPT1B locus. [provided by RefSeq, Jun 2009]
CHKB-CPT1B (HGNC:41998): (CHKB-CPT1B readthrough (NMD candidate)) The genes CHKB and CPT1B are adjacent on chromosome 22 and read-through transcripts are expressed that include exons from both loci. The read-through transcripts are candidates for nonsense-mediated mRNA decay (NMD) and are unlikely to express proteins. [provided by RefSeq, Jun 2009]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP6
Variant 22-50582768-G-A is Benign according to our data. Variant chr22-50582768-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 383214.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.000814 (124/152310) while in subpopulation AMR AF = 0.00255 (39/15310). AF 95% confidence interval is 0.00192. There are 0 homozygotes in GnomAd4. There are 59 alleles in the male GnomAd4 subpopulation. Median coverage is 34. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CHKBNM_005198.5 linkc.14C>T p.Ala5Val missense_variant Exon 1 of 11 ENST00000406938.3 NP_005189.2 Q9Y259-1A0A024R4X4
CHKB-CPT1BNR_027928.2 linkn.232C>T non_coding_transcript_exon_variant Exon 1 of 30

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CHKBENST00000406938.3 linkc.14C>T p.Ala5Val missense_variant Exon 1 of 11 1 NM_005198.5 ENSP00000384400.3 Q9Y259-1

Frequencies

GnomAD3 genomes
AF:
0.000815
AC:
124
AN:
152192
Hom.:
0
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.00101
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00255
Gnomad ASJ
AF:
0.00202
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000470
Gnomad OTH
AF:
0.00191
GnomAD2 exomes
AF:
0.000608
AC:
105
AN:
172824
AF XY:
0.000677
show subpopulations
Gnomad AFR exome
AF:
0.00195
Gnomad AMR exome
AF:
0.00118
Gnomad ASJ exome
AF:
0.00140
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000642
Gnomad NFE exome
AF:
0.000535
Gnomad OTH exome
AF:
0.00130
GnomAD4 exome
AF:
0.000380
AC:
541
AN:
1425206
Hom.:
2
Cov.:
32
AF XY:
0.000415
AC XY:
293
AN XY:
706510
show subpopulations
African (AFR)
AF:
0.000963
AC:
31
AN:
32182
American (AMR)
AF:
0.00136
AC:
54
AN:
39808
Ashkenazi Jewish (ASJ)
AF:
0.00138
AC:
35
AN:
25454
East Asian (EAS)
AF:
0.00
AC:
0
AN:
37590
South Asian (SAS)
AF:
0.00
AC:
0
AN:
82524
European-Finnish (FIN)
AF:
0.0000417
AC:
2
AN:
47980
Middle Eastern (MID)
AF:
0.00223
AC:
12
AN:
5370
European-Non Finnish (NFE)
AF:
0.000301
AC:
330
AN:
1095402
Other (OTH)
AF:
0.00131
AC:
77
AN:
58896
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
30
59
89
118
148
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000814
AC:
124
AN:
152310
Hom.:
0
Cov.:
34
AF XY:
0.000792
AC XY:
59
AN XY:
74488
show subpopulations
African (AFR)
AF:
0.00101
AC:
42
AN:
41572
American (AMR)
AF:
0.00255
AC:
39
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00202
AC:
7
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5168
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.000471
AC:
32
AN:
68012
Other (OTH)
AF:
0.00189
AC:
4
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
8
16
23
31
39
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000550
Hom.:
1
Bravo
AF:
0.000895
ExAC
AF:
0.000460
AC:
52
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Jun 28, 2016
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Megaconial type congenital muscular dystrophy Benign:1
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.50
T
BayesDel_noAF
Benign
-0.49
CADD
Benign
21
DANN
Uncertain
1.0
DEOGEN2
Benign
0.092
T
Eigen
Benign
-1.0
Eigen_PC
Benign
-0.96
FATHMM_MKL
Benign
0.026
N
LIST_S2
Benign
0.46
T
M_CAP
Uncertain
0.13
D
MetaRNN
Benign
0.0060
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.0
N
PhyloP100
-0.010
PrimateAI
Uncertain
0.74
T
PROVEAN
Benign
-0.34
N
REVEL
Benign
0.032
Sift
Benign
0.054
T
Sift4G
Benign
0.17
T
Polyphen
0.0060
B
Vest4
0.16
MutPred
0.33
Gain of sheet (P = 0.0028);
MVP
0.45
ClinPred
0.028
T
GERP RS
3.4
PromoterAI
-0.11
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.040
gMVP
0.32
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.27
Details are displayed if max score is > 0.2
DS_DG_spliceai
0.27
Position offset: 2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs199703765; hg19: chr22-51021197; API